On August 12, 2026, Eli Lilly filed six lawsuits against U.S companies for allegedly selling or facilitating access to unauthorized retatrutide products. The defendants are Aesthetic Envy Cosmetic Centers, Astra LLC, Legendary Peptides, Striker Pharmacy, Texas Peptides and Lone Star Peptide Co, and span several parts of the market, including online peptide sellers, a pharmacy and a medical spa business….
By: Vedder
By: Vedder
